- Home
- IMNM vs SPFI Comparison
IMNM vs SPFI Comparison
Compare IMNM & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- SPFI
- Stock Information
- Founded
- IMNM 2006
- SPFI 1941
- Country
- IMNM United States
- SPFI United States
- Employees
- IMNM N/A
- SPFI N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- SPFI Major Banks
- Sector
- IMNM Health Care
- SPFI Finance
- Exchange
- IMNM Nasdaq
- SPFI Nasdaq
- Market Cap
- IMNM 806.1M
- SPFI 647.7M
- IPO Year
- IMNM 2020
- SPFI 2019
- Fundamental
- Price
- IMNM $9.52
- SPFI $33.80
- Analyst Decision
- IMNM Strong Buy
- SPFI Buy
- Analyst Count
- IMNM 5
- SPFI 2
- Target Price
- IMNM $28.60
- SPFI $40.50
- AVG Volume (30 Days)
- IMNM 1.2M
- SPFI 28.7K
- Earning Date
- IMNM 03-27-2025
- SPFI 01-24-2025
- Dividend Yield
- IMNM N/A
- SPFI 1.77%
- EPS Growth
- IMNM N/A
- SPFI N/A
- EPS
- IMNM N/A
- SPFI 2.92
- Revenue
- IMNM $10,129,000.00
- SPFI $190,870,000.00
- Revenue This Year
- IMNM N/A
- SPFI N/A
- Revenue Next Year
- IMNM N/A
- SPFI $7.23
- P/E Ratio
- IMNM N/A
- SPFI $11.58
- Revenue Growth
- IMNM N/A
- SPFI N/A
- 52 Week Low
- IMNM $8.97
- SPFI $24.05
- 52 Week High
- IMNM $30.96
- SPFI $40.91
- Technical
- Relative Strength Index (RSI)
- IMNM 40.66
- SPFI 36.67
- Support Level
- IMNM $9.67
- SPFI $35.09
- Resistance Level
- IMNM $10.68
- SPFI $37.35
- Average True Range (ATR)
- IMNM 0.80
- SPFI 0.97
- MACD
- IMNM -0.08
- SPFI -0.20
- Stochastic Oscillator
- IMNM 0.34
- SPFI 0.00
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About SPFI South Plains Financial Inc.
South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has two reportable segments: banking and insurance.